Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 187

Similar articles for PubMed (Select 19693938)

1.

Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study.

Troncone G, Cozzolino I, Fedele M, Malapelle U, Palombini L.

Diagn Cytopathol. 2010 Mar;38(3):172-6. doi: 10.1002/dc.21166.

PMID:
19693938
2.

Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.

Wobker SE, Kim LT, Hackman TG, Dodd LG.

Cancer Cytopathol. 2015 Jun 16. doi: 10.1002/cncy.21575. [Epub ahead of print]

PMID:
26080065
3.

DNA methylation analysis for the diagnosis of thyroid nodules - a pilot study with reference to BRAFV 600E mutation and cytopathology results.

Chang H, Shin BK, Kim A, Kim HK, Kim BH.

Cytopathology. 2015 May 18. doi: 10.1111/cyt.12248. [Epub ahead of print]

PMID:
25988212
4.

Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.

Harada S, Agosto-Arroyo E, Levesque JA, Alston E, Janowski KM, Coshatt GM, Eltoum IA.

Cancer Cytopathol. 2015 May 8. doi: 10.1002/cncy.21561. [Epub ahead of print]

PMID:
25955105
5.

Evaluation of the Real-Q BRAF V600E Detection Assay in Fine-Needle Aspiration Samples of Thyroid Nodules.

Park KS, Oh YL, Ki CS, Kim JW.

J Mol Diagn. 2015 Jul;17(4):431-7. doi: 10.1016/j.jmoldx.2015.03.006. Epub 2015 Apr 30.

PMID:
25937618
6.

Molecular analysis of residual ThinPrep material from thyroid FNAs increases diagnostic sensitivity.

Krane JF, Cibas ES, Alexander EK, Paschke R, Eszlinger M.

Cancer Cytopathol. 2015 Jun;123(6):356-61. doi: 10.1002/cncy.21546. Epub 2015 Apr 29.

PMID:
25926393
7.

Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique.

Shi Q, Ibrahim A, Herbert K, Carvin M, Randolph M, Post KM, Curless K, Chen S, Cramer HM, Cheng L, Wu HH.

Am J Clin Pathol. 2015 Apr;143(4):500-4. doi: 10.1309/AJCP5BG0KUEOJCVS.

PMID:
25780001
8.

Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.

Bhatia P, Deniwar A, Friedlander P, Aslam R, Kandil E.

Anticancer Res. 2015 Mar;35(3):1237-41. Review.

PMID:
25750270
9.

VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases.

Lee SR, Yim H, Han JH, Lee KB, Lee J, Soh EY, Kim DJ, Chung YS, Jeong SY, Sheen SS, Park SH, Kim JH.

Am J Clin Pathol. 2015 Mar;143(3):437-44. doi: 10.1309/AJCPOBI5CUZIBMO1.

PMID:
25696803
10.

Molecular testing of thyroid fine-needle aspirations improves presurgical diagnosis and supports the histologic identification of minimally invasive follicular thyroid carcinomas.

Eszlinger M, Piana S, Moll A, Bösenberg E, Bisagni A, Ciarrocchi A, Ragazzi M, Paschke R.

Thyroid. 2015 Apr;25(4):401-9. doi: 10.1089/thy.2014.0362. Epub 2015 Feb 26.

PMID:
25629769
11.
12.

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.

Bongiovanni M, Molinari F, Eszlinger M, Paschke R, Barizzi J, Merlo E, Giovanella L, Fasolini F, Cattaneo F, Ramelli F, Mazzucchelli L, Frattini M.

Cytopathology. 2014 Dec 8. doi: 10.1111/cyt.12226. [Epub ahead of print]

PMID:
25487739
13.

How do liquid-based preparations of thyroid fine-needle aspiration compare with conventional smears? An analysis of 5475 specimens.

Nagarajan N, Schneider EB, Ali SZ, Zeiger MA, Olson MT.

Thyroid. 2015 Mar;25(3):308-13. doi: 10.1089/thy.2014.0394. Epub 2015 Jan 5.

PMID:
25420135
14.

Clinical Implication of Highly Sensitive Detection of the BRAFV600E Mutation in Fine-Needle Aspirations According to the Thyroid Bethesda System in Patients With Conventional Papillary Thyroid Carcinoma.

Seo JY, Choi JR, Moon HJ, Kim EK, Han KH, Kim H, Kwak JY.

Ann Otol Rhinol Laryngol. 2015 May;124(5):392-9. doi: 10.1177/0003489414560433. Epub 2014 Nov 17.

PMID:
25404749
15.

Detection of BRAF mutation in metastatic melanoma utilizing cell-transferred cytological smears.

Chen S, Randolph M, Cramer HM, Watkins T, McCullough H, Post KM, Sen JD, Cheng L, Wu HH.

Acta Cytol. 2014;58(5):478-82. doi: 10.1159/000368273. Epub 2014 Oct 29.

PMID:
25359156
16.

[Clinical role of BRAF V600E mutation testing in thyroid nodules].

Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Jun;49(6):468-72. Chinese.

PMID:
25241863
17.

BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.

Agretti P, Niccolai F, Rago T, De Marco G, Molinaro A, Scutari M, Di Cosmo C, Di Coscio G, Vitale M, Maccheroni M, Vitti P, Tonacchera M.

J Endocrinol Invest. 2014 Oct;37(10):1009-14. doi: 10.1007/s40618-014-0166-6. Epub 2014 Sep 7.

PMID:
25194426
18.

Keynote Lecture: KN03 APPLICATION OF CYTOLOGICAL SAMPLES FOR MOLECULAR BIOLOGY.

Schmitt FC.

Pathology. 2014 Oct;46 Suppl 2:S1. doi: 10.1097/01.PAT.0000454054.85406.3a.

PMID:
25188044
19.

Role of BRAF molecular analysis in the management of papillary thyroid carcinoma: analysis of cytological and histological samples.

Capelli L, Marfisi C, Puccetti M, Saragoni L, De Paola F, Zaccaroni A, Chiadini E, Gagliardi L, Ferretti G, Zoli W, Ulivi P.

Cytopathology. 2014 Aug 14. doi: 10.1111/cyt.12199. [Epub ahead of print]

PMID:
25123949
20.

Assessment of molecular testing in fine-needle aspiration biopsy samples: an experience in a Chinese population.

Liu S, Gao A, Zhang B, Zhang Z, Zhao Y, Chen P, Ji M, Hou P, Shi B.

Exp Mol Pathol. 2014 Oct;97(2):292-7. doi: 10.1016/j.yexmp.2014.08.005. Epub 2014 Aug 8.

PMID:
25111330
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk